2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 193

Evaluation of a Diversionary Back Pain Service
Abstract Number: 194

Kinesiophobia Moderates the Association between Anxiety and Disability in Chronic Low Back Pain
Abstract Number: 195

Health Care Costs of Patients with Systemic Lupus Erythematosus (SLE) Versus Control Patients As a Function of Disease Severity: Analysis of the Betriebskrankenkassen German Sickness Fund
Abstract Number: 196

Patient Assistance Program Outcomes in a Community Clinic Setting
Abstract Number: 197

Process Evaluation of the Making It Work Program, an Online Program to Help People with Inflammatory Arthritis Remain Employed
Abstract Number: 198

The Impact of Electronic Consults (E-Consults) on Positive ANA Referrals in a Veteran Population
Abstract Number: 199

Incremental Direct Medical Costs of Systemic Lupus Erythematosus Patients in the Years Preceding Diagnosis and the Impact of Sex: A General Population-Based Study
Abstract Number: 200

Implementation and Evaluation of a Novel Nurse-Led Telemedicine Intervention for Dose Escalation of Urate-Lowering Therapy in Gout: A Clinical Practice Improvement Project
Abstract Number: 201

Computer Learning (artificial intelligence) to Create a Computer-Based Triage Tool Classifying Referrals As Inflammatory or Non-Inflammatory Requiring Only Patient Reported Information
Abstract Number: 202

Analysis of Provider-to-Provider Variability in the Use of Biologics: Data from the Rheumatology Informatics System for Effectiveness Registry
Abstract Number: 203

Intensive Care Unit Admissions Among Patients with Rheumatic Diseases at a Tertiary Care Center
Abstract Number: 204

Healthcare Utilization Among Young Adults Transitioning from Pediatric to Adult Care in a Safety Net Population
Abstract Number: 205

What Is the Value of the Prior Authorization Process in Specialty Drug Therapy?
Abstract Number: 206

Real World IGRA Testing in Rheumatology Practice
Abstract Number: 207

Direct Medical Costs of Systemic Lupus Erythematosus in South Korea

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].